Our Focus
By enabling colonization in the gut we believe that this novel technology will revolutionize live bacterial therapeutic interventions for other pathological states where there is erosion of the mucosal barrier.
Erosion of the physical mucus barrier leads to breaches and penetration of toxins, proteins and microbiota to enterocytes of the intestine. The result is collectively termed “leaky gut” and often associated with low levels of chronic GI and systemic inflammation. Thus, our technology will serve several unmet medical needs when applied as an intervention to fortify the mucosal barrier in states where breaches are documented.
Research and Development